arrow
K

Konrad Stawiski

Dana-Farber Cancer Institute
H指数:18
被引数:960

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline Lymphocyte Count Outperforms Dosimetry and Inflammatory Markers for Predicting Severe Radiation-Induced Lymphopenia in Rectal Cancer

基线淋巴细胞计数优于剂量测定和炎症标志物,用于预测直肠癌严重放射性淋巴细胞减少症

2026-08-300
PRE
Circulating microRNAs as prognostic biomarkers in patients with oropharyngeal cancer undergoing radiotherapy: temporal dynamics analysis

循环microRNAs作为接受放疗的口咽癌患者的预后生物标志物:时间动态分析

2026-07-180
OA
Serum citrulline as a prognostic marker in patients with oropharyngeal carcinoma treated with chemoradiotherapy

血清瓜氨酸作为接受放化疗的口咽癌患者的预后标志物

2026-01-010
PRE
Dose-volume metric-based prediction of radiotherapy-induced lymphocyte loss in patients with non-small-cell lung cancer treated with modern radiotherapy techniques
2024-04-010
OAAI
Co-expression of HERV-R, CCND1, BRAF, FOXA1, TMPRSS2, ATF4 and low expression of BAZ1B and KMT2D is associated with early detection and poor prognosis of prostate cancer in African Black men from Nigeria
2024-03-220
PRE
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer
2023-11-243
OAAI
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients
2023-06-013
PRE